Pathway Genomics and 23andMe Team with Harvard and U. Michigan to Address the Impact of Personal Genomic Tests

Pathway Genomics and 23andMe, the consumer genomics companies, have teamed up with Harvard Medical School (Brigham and Women’s Hospital) and University of Michigan to study the impact of personal genomics studies.

The impact of personal genomics study named PGen, hopes to throw more light on the expectations of consumers of personal genomic services, their motivations to use the services, and the psychological and behavioral impact of personal genetic. PGen will also address the ethical, legal and social issues in personal genomics.

The PGen study funded by National Human Genome Research Institute was announced in early April and Pathway Genomics has begun enrolling participants to take part in the study. The PGen participants have the chance to buy genetic testing services from Pathway Genomics for a reduced price of $25. Pathway genomics will perform three genetic tests: Drug Response, Pre-Pregnancy Planning (Carrier Status), and Health Conditions.

The PGen study also involve three research surveys to understand the personal genomic consumers. The participants don’t go empty handed. In addition to the results of the genetic tests, Pathway Genomics will offer Amazon gift cards of worth $50 ($10, $20, and $20 Amazon Gift cards after finishing each survey). The Pgen enrollment is open. Both Men and women of 18 years and older from US are eligible (except for NY residents).

How Does the Pathway Genomics’ PGen Study Works?

Upon registering and paying online, the participants will go through an initial research survey. After the completion of initial survey the participant will receive a saliva collection kit for genetic testing. The participants will also go through two more surveys; one after two to three weeks after getting the test results and the other six months after the test results.

Visit to learn more PGen study and enrolling. If you have more questions, PGen website asks you to contact

Sarah Kalia, Project Manager at Brigham and Women’s Hospital at If you have questions about Pathway Genomics’ participation in this project, please contact

Speak Your Mind